Skip to main content
Livermore
Livermore
ZHEN

Vigil Neuroscience, Inc.

VIGLDelisted Aug 5, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827087

Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Vigil Neuroscience, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
+7 vs. Q1 2023
Shares held
25.8M
+700.3K (+2.8%) vs. Q1 2023
Total value
$242.1M
−$3.34M (−1.4%) vs. Q1 2023
New holders
15
12 more added
Sold out
8
8 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 47 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 47 institutionsQ2 2022: 35 institutionsQ3 2022: 33 institutionsQ4 2022: 37 institutionsQ1 2023: 41 institutionsQ2 2023: 47 institutionsQ3 2023: 45 institutionsQ4 2023: 46 institutionsQ1 2024: 54 institutionsQ2 2024: 58 institutionsQ3 2024: 52 institutionsQ4 2024: 51 institutionsQ1 2025: 50 institutionsQ2 2025: 78 institutionsQ3 2025: 2 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $242.1M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $125.1MQ2 2022: $44.6MQ3 2022: $222.7MQ4 2022: $312.3MQ1 2023: $245.4MQ2 2023: $242.1MQ3 2023: $137.7MQ4 2023: $84.4MQ1 2024: $90.5MQ2 2024: $104.5MQ3 2024: $94.2MQ4 2024: $38.4MQ1 2025: $44.5MQ2 2025: $265.8MQ3 2025: $4.55KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VIGL and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20252$4.55K
Q2 202578$265.8M
Q1 202550$44.5M
Q4 202451$38.4M
Q3 202452$94.2M
Q2 202458$104.5M
Q1 202454$90.5M
Q4 202346$84.4M
Q3 202345$137.7M
Q2 202347$242.1M
Q1 202341$245.4M
Q4 202237$312.3M
Q3 202233$222.7M
Q2 202235$44.6M
Q1 202247$125.1M
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q1 2023.

Institutions holding VIGL in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
State of Wyoming143$1.34K0.00%+42+41.6%Added
Tower Research Capital LLC (TRC)625$5.88K0.00%−857−57.8%Reduced
Metropolitan Life Insurance Co944$8.87K0.00%+944New
Ameritas Investment Partners, Inc.1,327$12.5K0.00%+1,327New
Legal & General Group Plc1,554$14.6K0.00%+1,554New
Amalgamated Bank1,563$15.0K0.00%+1,563New
Royal Bank of Canada3,499$33.0K0.00%+3,499New
California State Teachers Retirement System5,345$50.2K0.00%+5,345New
Wells Fargo & Company6,096$57.3K0.00%+6,010+6,988.4%Added
American International Group, Inc.7,734$72.7K0.00%+7,734New
MetLife Investment Management9,105$85.6K0.00%+9,105New
New York State Common Retirement Fund10,000$94.0K0.00%+10,000New
JPMorgan Chase & Co12,805$120.4K0.00%+12,805New
Goldman Sachs Group Inc13,008$122.3K0.00%−11,818−47.6%Reduced
PEAK6 Investments LLC14,337$134.8K0.01%+14,337New
Morgan Stanley15,625$146.9K0.00%−42,719−73.2%Reduced
Rhumbline Advisers16,358$153.8K0.00%+16,358New
Bank of America Corp20,133$189.3K0.00%+811+4.2%Added
Nuveen Asset Management, LLC24,715$232.3K0.00%+24,715New
Charles Schwab Investment Management Inc41,968$394.5K0.00%+41,968New
Bank of New York Mellon Corp48,488$455.8K0.00%+48,488New
Citigroup Inc69,077$649.3K0.00%−22,321−24.4%Reduced
Bank of Montreal73,243$728.0K0.00%+31,950+77.4%Added
Laurion Capital Management LP99,689$937.1K0.04%−30,511−23.4%Reduced
Barclays PLC104,902$986.1K0.00%+654+0.6%Added
Northern Trust Corp124,362$1.17M0.00%+102,127+459.3%Added
FMR LLC140,400$1.32M0.00%+53,676+61.9%Added
DAFNA Capital Management LLC172,308$1.62M0.44%00.0%Unchanged
Logos Global Management LP188,390$1.77M0.24%00.0%Unchanged
Trustees of Columbia University in the City of New York192,973$1.81M2.66%00.0%Unchanged
State Street Corp259,699$2.44M0.00%+223,960+626.7%Added
Geode Capital Management, LLC284,843$2.68M0.00%+172,451+153.4%Added
Harvard Management Co Inc289,460$2.72M0.27%00.0%Unchanged
OrbiMed Advisors LLC448,891$4.22M0.08%00.0%Unchanged
Rock Springs Capital Management LP471,958$4.44M0.11%00.0%Unchanged
Pivotal bioVenture Partners Investment Advisor LLC560,595$5.27M1.74%00.0%Unchanged
Cormorant Asset Management, LP616,786$5.80M0.33%00.0%Unchanged
Vanguard Group Inc792,236$7.45M0.00%+63,623+8.7%Added
BlackRock Inc.821,452$7.72M0.00%+719,366+704.7%Added
Deep Track Capital, LP1,773,409$16.7M0.78%−251,728−12.4%Reduced
BVF Inc1,813,633$17.0M0.48%00.0%Unchanged
Artal Group S.A.1,911,191$18.0M0.58%−332,161−14.8%Reduced
Deerfield Management Company, L.P. (Series C)2,052,010$19.3M0.41%00.0%Unchanged
Citadel Advisors LLC2,180,324$20.5M0.02%+18,528+0.9%Added
Northpond Ventures, LLC4,214,498$39.6M65.75%00.0%Unchanged
Atlas Venture Life Science Advisors, LLC5,836,874$54.9M6.83%00.0%Unchanged
Coppell Advisory Solutions LLC2,484––−814−24.7%Reduced
Millennium Management LLC0$00.00%−71,381−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−58,718−100.0%Sold out
Jane Street Group, LLC0$00.00%−27,184−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−18,705−100.0%Sold out
683 Capital Management, LLC0$00.00%−15,092−100.0%Sold out
Man Group plc0$00.00%–Sold out
Cannell Capital LLC0$00.00%−8,044−100.0%Sold out
UBS Group AG0$00.00%−592−100.0%Sold out
Coppell Advisory Solutions Corp.––––Not filed